U.S. Rep. Sharice Davids denounces federal court’s decision on access to abortion drug

The lone Kansas Democrat in Congress objects to a federal appeals court's decision to temporarily ban use of telemedicine to prescribe abortion drug.

By: Tim Carpenter

Outlets: Kansas Reflector

Published: May 4, 2026

Words: 388

Last Updated: 2 months, 3 weeks ago


Body Text Preview

TOPEKA — U.S. Rep. Sharice Davids of Kansas urged the public to contact lawmakers to express opposition to a federal appeals court’s order undercutting a U.S. Food and Drug Administration regulation broadening access to the abortion pill mifepristone.

A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit halted enforcement of an FDA rule adopted in 2023 permitting mifepristone to be prescribed without the patient seeing a healthcare provider in person. The …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

Register for Free Log in